文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

概述、更新以及从国际 EQ-5D-5L 估值工作中吸取的经验教训:EQ-5D-5L 估值议定书第 2 版。

Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.

机构信息

EuroQol Research Foundation, Rotterdam, The Netherlands.

EuroQol Research Foundation, Rotterdam, The Netherlands; Health Economics and Health Care Management, Bielefeld University, Bielefeld, Germany.

出版信息

Value Health. 2019 Jan;22(1):23-30. doi: 10.1016/j.jval.2018.05.010. Epub 2019 Jan 2.


DOI:10.1016/j.jval.2018.05.010
PMID:30661630
Abstract

A standardized 5-level EuroQol 5-dimensional questionnaire (EQ-5D-5L) valuation protocol was first used in national studies in the period 2012 to 2013. A set of problems encountered in this initial wave of valuation studies led to the subsequent refinement of the valuation protocol. To clarify lessons learned and how the protocol was updated when moving from version 1.0 to the current version 2.1 and 2.0, this article will (1) present the challenges faced in EQ-5D-5L valuation since 2012 and how these were resolved and (2) describe in depth a set of new challenges that have become central in currently ongoing research on how EQ-5D-5L health states should be valued and modeled.

摘要

自 2012 年以来,首个标准化的 5 级欧洲五维健康量表问卷(EQ-5D-5L)赋值方案首先被用于国家研究。在这波初始赋值研究中遇到了一系列问题,这导致了赋值方案的后续改进。为了阐明经验教训以及从版本 1.0 升级到当前的 2.1 和 2.0 版本时协议是如何更新的,本文将:(1)介绍自 2012 年以来在 EQ-5D-5L 赋值中面临的挑战,以及这些挑战是如何得到解决的;(2)深入描述在当前关于 EQ-5D-5L 健康状况应如何赋值和建模的研究中成为核心的一系列新挑战。

相似文献

[1]
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.

Value Health. 2019-1-2

[2]
A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol.

Value Health. 2014-6

[3]
Does the Introduction of the Ranking Task in Valuation Studies Improve Data Quality and Reduce Inconsistencies? The Case of the EQ-5D-5L.

Value Health. 2016-6

[4]
Effect of Health State Sampling Methods on Model Predictions of EQ-5D-5L Values: Small Designs Can Suffice.

Value Health. 2018-7-31

[5]
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.

Qual Life Res. 2019-6-14

[6]
Valuation of the EQ-5D-5L with composite time trade-off for the German population - an exploratory study.

Health Qual Life Outcomes. 2017-2-20

[7]
Valuing health-related quality of life: An EQ-5D-5L value set for England.

Health Econ. 2018-1

[8]
The Development and Strengthening of Methods for Valuing EQ-5D-5L – An Overview

2022

[9]
EQ-5D-Y as a Health-Related Quality of Life Instrument for Children and Adolescents: The Instrument's Characteristics, Development, Current Use, and Challenges of Developing Its Value Set.

Value Health. 2019-1

[10]
Quality Control Process for EQ-5D-5L Valuation Studies.

Value Health. 2017-3

引用本文的文献

[1]
Patient-reported symptom burden and health-related quality of life in patients with aggressive Non-Hodgkin lymphoma: a cross-sectional study.

BMC Cancer. 2025-9-1

[2]
Developing an EQ-5D-5L Value Set for Singapore.

Pharmacoeconomics. 2025-8-29

[3]
Electronic Patient-Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second-Line Chemotherapy: A Multicenter Observational Study.

Cancer Med. 2025-9

[4]
Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions.

Alzheimers Dement (N Y). 2025-8-4

[5]
Measuring and Valuing Health Using EuroQol Instruments: New Developments 2025 and Beyond.

Appl Health Econ Health Policy. 2025-7-24

[6]
An Australian Value Set for the EQ-5D-Y-3L.

Health Qual Life Outcomes. 2025-7-15

[7]
Association of Pharmacogenotyping and Patient-Reported Outcomes in Chronic Pain Management.

Health Serv Insights. 2025-7-12

[8]
A feasibility study of the costs and consequences of improving the oral health of older people in care homes: findings from the TOPIC study.

BMC Oral Health. 2025-7-2

[9]
Effect of normobaric and hyperbaric hyperoxia treatment on symptoms and cognitive capacities in Long COVID patients: a randomised placebo-controlled, prospective, double-blind trial.

Diving Hyperb Med. 2025-6-30

[10]
Health Utility and Symptom Scores in Patients With Advanced Malignant Pleural Mesothelioma Treated in a Real-World Setting.

JTO Clin Res Rep. 2025-2-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索